3.44 USD
+0.02 (+0.73%)
3.68 USD
+0.24 (+6.98%)
CCEL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. CCEL has a medium profitability rating, but doesn't score so well on its financial health evaluation. CCEL is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- CCEL had negative earnings in the past year.
- In the past year CCEL had a positive cash flow from operations.
- Of the past 5 years CCEL 4 years were profitable.
- Each year in the past 5 years CCEL had a positive operating cash flow.
1.2 Ratios
- CCEL's Return On Assets of -0.75% is in line compared to the rest of the industry. CCEL outperforms 47.06% of its industry peers.
- CCEL has a better Return On Invested Capital (7.64%) than 71.57% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for CCEL is in line with the industry average of 9.21%.
- The 3 year average ROIC (7.61%) for CCEL is below the current ROIC(7.64%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROIC | 7.64% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
1.3 Margins
- In the last couple of years the Profit Margin of CCEL has declined.
- CCEL's Operating Margin of 13.63% is amongst the best of the industry. CCEL outperforms 85.29% of its industry peers.
- CCEL's Operating Margin has declined in the last couple of years.
- CCEL has a Gross Margin of 77.07%. This is amongst the best in the industry. CCEL outperforms 91.18% of its industry peers.
- In the last couple of years the Gross Margin of CCEL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% |
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
2. Health
2.1 Basic Checks
- CCEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for CCEL has been reduced compared to 1 year ago.
- CCEL has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for CCEL has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 0.05, we must say that CCEL is in the distress zone and has some risk of bankruptcy.
- CCEL has a Altman-Z score of 0.05. This is in the lower half of the industry: CCEL underperforms 77.45% of its industry peers.
- The Debt to FCF ratio of CCEL is 1.36, which is an excellent value as it means it would take CCEL, only 1.36 years of fcf income to pay off all of its debts.
- CCEL has a better Debt to FCF ratio (1.36) than 87.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Altman-Z | 0.05 |
ROIC/WACC0.64
WACC11.99%
2.3 Liquidity
- CCEL has a Current Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
- CCEL has a Current ratio of 0.63. This is amonst the worse of the industry: CCEL underperforms 84.31% of its industry peers.
- A Quick Ratio of 0.60 indicates that CCEL may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.60, CCEL is doing worse than 81.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
- CCEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 94.34%, which is quite impressive.
- CCEL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -29.04% yearly.
- Looking at the last year, CCEL shows a decrease in Revenue. The Revenue has decreased by -0.29% in the last year.
- The Revenue has been growing slightly by 0.11% on average over the past years.
EPS 1Y (TTM)94.34%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)-0.29%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-2.99%
3.2 Future
- The Earnings Per Share is expected to decrease by -202.32% on average over the next years. This is quite bad
- The Revenue is expected to decrease by -3.22% on average over the next years.
EPS Next Y87%
EPS Next 2Y-202.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.55%
Revenue Next 2Y-3.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CCEL. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CCEL. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCEL indicates a rather cheap valuation: CCEL is cheaper than 91.18% of the companies listed in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCEL indicates a rather cheap valuation: CCEL is cheaper than 97.06% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.48 | ||
| EV/EBITDA | 5.63 |
4.3 Compensation for Growth
- CCEL's earnings are expected to decrease with -202.32% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-202.32%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 25.39%, CCEL is a good candidate for dividend investing.
- In the last 3 months the price of CCEL has falen by -24.40%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- Compared to an average industry Dividend Yield of 0.59, CCEL pays a better dividend. On top of this CCEL pays more dividend than 100.00% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.85, CCEL pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 25.39% |
5.2 History
- CCEL has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- The earnings of CCEL are negative and hence is the payout ratio. CCEL will probably not be able to sustain this dividend level.
DP-1109.12%
EPS Next 2Y-202.32%
EPS Next 3YN/A
3.44
+0.02 (+0.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-15 2025-10-15/amc
Earnings (Next)02-26 2026-02-26/amc
Inst Owners7.19%
Inst Owner Change0%
Ins Owners41.98%
Ins Owner Change1.89%
Market Cap27.73M
Revenue(TTM)31.75M
Net Income(TTM)-473.50K
Analysts43.33
Price Target8.67 (152.03%)
Short Float %0.17%
Short Ratio1.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 25.39% |
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP-1109.12%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)227.45%
Min EPS beat(2)178.43%
Max EPS beat(2)276.47%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.61%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-3.33%
Revenue beat(4)0
Avg Revenue beat(4)-2.41%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-2.16%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-125%
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.87 | ||
| P/FCF | 4.48 | ||
| P/OCF | 4.36 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.63 |
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)0.77
FCFY22.3%
OCF(TTM)0.79
OCFY22.92%
SpS3.94
BVpS-1.84
TBVpS-2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROCE | 9.68% | ||
| ROIC | 7.64% | ||
| ROICexc | 8.24% | ||
| ROICexgc | 8.84% | ||
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% | ||
| FCFM | 19.48% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
ROICexc(3y)7.98%
ROICexc(5y)14.72%
ROICexgc(3y)8.63%
ROICexgc(5y)16.85%
ROCE(3y)9.64%
ROCE(5y)14.41%
ROICexgc growth 3Y-17.95%
ROICexgc growth 5Y-25.17%
ROICexc growth 3Y-16.74%
ROICexc growth 5Y-23.68%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 17.31% | ||
| Cap/Sales | 0.54% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 119.5% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 0.05 |
F-Score7
WACC11.99%
ROIC/WACC0.64
Cap/Depr(3y)548.95%
Cap/Depr(5y)370.25%
Cap/Sales(3y)23.15%
Cap/Sales(5y)15.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.34%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-30.77%
EPS Next Y87%
EPS Next 2Y-202.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.29%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-2.99%
Revenue Next Year-1.55%
Revenue Next 2Y-3.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.52%
EBIT growth 3Y-9.92%
EBIT growth 5Y-12.52%
EBIT Next Year43.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y112.76%
FCF growth 3Y-15.98%
FCF growth 5Y-8.62%
OCF growth 1Y-20.62%
OCF growth 3Y-8.81%
OCF growth 5Y-1.01%
CRYO-CELL INTL INC / CCEL FAQ
Can you provide the ChartMill fundamental rating for CRYO-CELL INTL INC?
ChartMill assigns a fundamental rating of 3 / 10 to CCEL.
What is the valuation status of CRYO-CELL INTL INC (CCEL) stock?
ChartMill assigns a valuation rating of 2 / 10 to CRYO-CELL INTL INC (CCEL). This can be considered as Overvalued.
Can you provide the profitability details for CRYO-CELL INTL INC?
CRYO-CELL INTL INC (CCEL) has a profitability rating of 5 / 10.
Can you provide the financial health for CCEL stock?
The financial health rating of CRYO-CELL INTL INC (CCEL) is 3 / 10.
Can you provide the dividend sustainability for CCEL stock?
The dividend rating of CRYO-CELL INTL INC (CCEL) is 4 / 10 and the dividend payout ratio is -1109.12%.